Study Finds Few Adverse Events Following OPAT Containing Cefazolin And Ceftriaxone Were Identified Using Routine Laboratory Monitoring

December 08, 2023

Healio (12/7, Stulpin) reports, “Few adverse events following outpatient parenteral antimicrobial therapy containing cefazolin and ceftriaxone were identified using routine laboratory monitoring, leading researchers to say the practice may be ‘excessive.’” According to researchers, “programs could likely safely implement less intensive monitoring strategies than IDSA guidelines currently recommend.” The findings were published in Open Forum Infectious Diseases.